Anebulo Pharmaceuticals provides update on going private transaction

Anebulo Pharmaceuticals (ANEB) announced an update on its current going private transaction. After announcing a going private transaction on July 23, the company received inbound interest from potential financial and strategic partners. The board will review all strategic alternatives available to the company, including the proposed going private transaction and related reverse stock split, a sale of the company’s assets and/or a merger transaction. While the strategic review process is ongoing, we currently plan to move forward with holding a special stockholder meeting to approve the proposed reverse stock split.